CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol. 2016;22(3):339-349.   Published online 2016 September 25    DOI: https://doi.org/10.3350/cmh.2016.0021

Excel Download

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Clinical and Molecular Hepatology. 2016;22(3):339-349   Crossref logo
Link1 Link2 Link3

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Liver International. 2016;37(2):309-310   Crossref logo
Link1 Link2

Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Hepatology Research. 2018;48(11):862-871   Crossref logo
Link1 Link2

44 PERFORMANCE OF HEPATOCELLULAR CARCINOMA RISK SCORES IN CHRONIC HEPATITIS B PATIENTS RECEIVING ENTECAVIR TREATMENT
Journal of Hepatology. 2013;58:S19   Crossref logo
Link1 Link2

On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
Hepatology. 2014;59(3):986-995   Crossref logo
Link1 Link2

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Clinical and Molecular Hepatology. 2016;22(3):336-338   Crossref logo
Link1 Link2 Link3

521 HEPATOCELLULAR CARCINOMA DEVELOPMENT IN HBe-NEGATIVE HEPATITIS B CIRRHOTIC PATIENTS WITH ENTECAVIR TREATMENT
Journal of Hepatology. 2013;58:S214   Crossref logo
Link1 Link2

Does long-term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis B virus infection?
Hepatology. 2014;59(5):2053-2053   Crossref logo
Link1 Link2

464 Impact of Nucleoside Analog Entecavir on Survival of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma
Gastroenterology. 2012;142(5):S-916   Crossref logo
Link1 Link2

Does interferon therapy prevent hepatocellular carcinoma in patients with chronic hepatitis C?
Gastroenterology. 1999;117(3):738-740   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.